Details of the Drug Formulations

General Information of Drug (ID: DMWA24P)

Drug Name
IPI-145 Drug Info
Synonyms Duvelisib; 1201438-56-3; INK-1197; UNII-610V23S0JI;
Indication
Disease Entry ICD 11 Status REF
Follicular lymphoma 2A80 Approved [1]
Small lymphocytic lymphoma 2A82.0 Approved [1]
Arthritis FA20 Phase 3 [2]
Cross-matching ID
PubChem CID
50905713
ChEBI ID
CHEBI:131169
CAS Number
1201438-56-3
TTD ID
D0RU0O
VARIDT ID
DR00276
ACDINA ID
D01025

Full List of Drug Formulations Containing This Drug

Duvelisib 15 mg capsule
Company Formulation ID FDA Description
Verastem F24050 Colloidal Silicon Dioxide; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Gelatin; Titanium Dioxide; Black Ink; Red Iron Oxide
------------------------------------------------------------------------------------
Duvelisib 25 mg capsule
Company Formulation ID FDA Description
Verastem F24051 Colloidal Silicon Dioxide; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Gelatin; Titanium Dioxide; Black Ink; Red Iron Oxide
------------------------------------------------------------------------------------

References

1 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7795).